Health Canada Renewed Injection Site Exemptions Despite Opposition
Health Canada reportedly ignored warnings from police, community outrage following a fatal shooting, and provincial pushback when renewing exemptions for supervised injection sites.
13 stories found
Health Canada reportedly ignored warnings from police, community outrage following a fatal shooting, and provincial pushback when renewing exemptions for supervised injection sites.
Health Canada has announced new conditions for Grifols, S.A. (GRFS) plasma collection centers, impacting the company's operations in the country.

Health Canada has issued a warning against the use of unauthorized injectable peptide drugs marketed for anti-aging, weight loss, or wellness, citing potential serious side effects.

Health Canada said it received two reports of fatal adverse reactions involving plasma donors, one recorded in October 2025 and another on January 30, 2026. The post Nigerian student, one other die…

CBC News has learned two people — including a 22-year-old international student — died after giving plasma at Winnipeg collection centres that pay people for their donations.
Biocon has received approval from Health Canada for its Bosaya and Vevzuo biosimilars, as reported by TradingView.

Health Canada has approved Neffy, a nasal spray, as the first needle-free epinephrine treatment for severe allergic reactions.

Health Canada has concluded that two deaths occurring after plasma donations in Winnipeg were not connected to the donation process itself. The federal health regulator's assessment found no evidence of machine malfunction, stating that the equipment performed as expected.

In the last decade, four people have died in Canada after giving plasma, and three of those deaths happened in Manitoba, Health Canada says.

Despite warnings from Health Canada regarding the purchase of peptides online, CBC News successfully demonstrated the ease with which these substances can be bought from companies operating in a grey market.
Apotex has secured tentative approval from the FDA for its generic version of Ozempic, while other drug manufacturers await similar decisions from Health Canada.

Health Canada has placed new terms and conditions on plasma donation company Grifols' centers following multiple failed inspections that revealed 'recurring, systemic deficiencies,' while also reviewing two deaths in Winnipeg linked to the company, leading to new restrictions in Canada.

Paid plasma could be banned in Manitoba, the province's health minister said after two fatal adverse reactions at Winnipeg collection centres were reported to Health Canada.